Significant Ownership of Shay Capital LLC

Signature - Title
Elan Foxman - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Shay Capital LLC.

Notify me when Shay Capital LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Shay Capital LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TLYS Tilly's, Inc. Class A Common Stock, par value $0.001 per share 15% $6,542,700 +$1,280,084 3,390,000 +24% Shay Capital LLC 30 Jun 2025
LVTX LAVA Therapeutics NV Common shares, par value (euro) 0.12 per share 9.9% $3,972,497 2,596,403 Shay Capital LLC 19 Sep 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, $0.00001 par value per share 7.3% $2,035,520 171,629 Shay Capital LLC 24 Oct 2025
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 6.3% $2,057,944 810,214 Shay Capital LLC 15 May 2025
DMYY dMY Squared Technology Group, Inc. Class A Common Stock, par value $0.0001 per share 5.4% $1,738,729 125,359 Shay Capital LLC 26 Sep 2025
CTRN Citi Trends Inc Common stock, par value $0.01 5.1% $8,653,773 441,970 Shay Capital LLC 11 Apr 2025
NVRO Nevro Corp Common Stock, $0.001 par value per share 4.2% $9,179,090 1,571,762 Shay Capital LLC 31 Dec 2024
XELA Exela Technologies, Inc. Common Stock, Par Value $0.0001 per share 0.63% $87,800 175,600 Shay Capital LLC 31 Dec 2024

Schedules 13D/G Reported by Shay Capital LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.